How Much Does Spironolactone Cost in Montana in 2026?

Montana Cash Prices for Generic Spironolactone

The average cash price for generic spironolactone across Montana retail pharmacies in 2026 sits at approximately $15 per month. That is a fraction of Pfizer's listed brand price of $80 per month, and it places spironolactone among the least expensive prescription acne treatments available in the state.

Price variation between pharmacies can be significant. A Walmart or Costco pharmacy in Billings or Missoula may fill a 30-day supply of spironolactone 100 mg for under $10, while independent pharmacies in smaller towns like Havre or Miles City sometimes charge $20 to $25 for the same prescription. The drug has been generic since the early 1980s, and multiple manufacturers produce it, which keeps wholesale acquisition costs low 1.

Dose matters. Most dermatologists start women with hormonal acne at 50 mg daily and titrate up to 100 or 200 mg daily based on clinical response. Layton et al. confirmed that doses between 100 and 200 mg daily produced the strongest anti-androgen effect on acne lesion counts 2. A 200 mg daily regimen doubles the tablet count, but even at that dose, generic pricing in Montana rarely exceeds $25 per month cash-pay.

Pharmacies in university towns (Bozeman, Missoula) tend to stock spironolactone more consistently because demand from younger female patients is higher. If you live in a rural county, calling ahead to confirm availability saves a wasted trip.

Montana Medicaid and Spironolactone Coverage

Montana Medicaid does not cover spironolactone for hormonal acne or hirsutism. These are off-label indications, and the state's preferred drug list excludes off-label dermatologic uses for this medication.

Spironolactone does carry FDA approval for heart failure, edema associated with hepatic cirrhosis, nephrotic syndrome, and primary hyperaldosteronism 1. Montana Medicaid will cover spironolactone when prescribed for one of those on-label cardiovascular or endocrine diagnoses. The distinction is the diagnosis code submitted on the claim, not the drug itself.

For Medicaid enrollees who need spironolactone specifically for acne, the practical workaround is paying cash. At $15 per month, the out-of-pocket burden is manageable for many patients, though it is not trivial for those on fixed incomes. Some providers have reported success requesting prior authorization when a patient has concurrent hypertension or fluid retention alongside hormonal acne, because the cardiovascular indication provides a covered pathway. That approach requires documentation of the cardiovascular condition and is not guaranteed.

The Endocrine Society's 2014 clinical practice guideline on hirsutism recommended spironolactone as first-line pharmacotherapy for women with androgen-dependent skin conditions, lending clinical weight to coverage arguments even when payers are reluctant to reimburse.

Private Insurance Coverage in Montana

Most commercial health plans available through the Montana marketplace or employer-sponsored coverage do include generic spironolactone on their formularies. Blue Cross Blue Shield of Montana, PacificSource, and the Montana State Employee Group Benefits Plan all list generic spironolactone as a Tier 1 generic, which typically means copays between $0 and $15 per month.

The key variable is diagnosis coding. When a prescriber submits a claim with an L70.0 ICD-10 code (acne vulgaris) rather than an I50.x code (heart failure), some plans apply different coverage rules. Plans with broad off-label coverage policies will still pay. Plans with narrow formulary restrictions may deny the claim and require a prior authorization explaining the clinical rationale.

A 2023 analysis by the American Academy of Dermatology found that prior authorization denial rates for spironolactone in dermatologic indications ranged from 8% to 22% across commercial payers nationally. Montana-specific data is limited, but the state's small insurer market (dominated by BCBS and PacificSource) tends to follow national formulary trends.

If your plan denies coverage, the appeal process in Montana requires the insurer to respond within 30 days for non-urgent requests. Your dermatologist can submit a letter of medical necessity citing the Layton et al. evidence base 2 and the Endocrine Society guideline. Meanwhile, filling at cash price keeps treatment uninterrupted during the appeal.

Compounded Spironolactone in Montana

Compounded spironolactone is legal in Montana through licensed 503A compounding pharmacies. This matters for two clinical scenarios: patients who need a topical formulation (typically 5% spironolactone cream) and patients who require a dose or delivery form not commercially available.

503A pharmacies compound medications pursuant to individual patient prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act. Montana does not impose additional state-level restrictions beyond federal 503A requirements, so any licensed compounding pharmacy operating in the state can prepare spironolactone formulations 3.

Topical spironolactone has gained attention as a localized anti-androgen for acne. A randomized controlled trial published in the Journal of the American Academy of Dermatology found that 5% topical spironolactone reduced inflammatory lesions by 50% over 12 weeks in women with mild to moderate hormonal acne 4. The topical route avoids systemic side effects like potassium elevation, menstrual irregularity, and breast tenderness that oral spironolactone can produce.

Compounded topical spironolactone pricing in Montana varies by pharmacy. Expect to pay between $30 and $75 for a 30-day supply of a compounded cream or gel, depending on the pharmacy's compounding fees and the base vehicle used. Compounded medications are rarely covered by insurance regardless of diagnosis, so this cost is almost always out-of-pocket.

Montana compounding pharmacies with reliable spironolactone availability include those in Billings, Great Falls, and Missoula. Rural patients can often have compounded prescriptions shipped within the state, as Montana permits intrastate shipping of 503A compounded products.

Discount Programs and Savings Cards

Several pathways can push spironolactone costs below the already-low $15 cash average in Montana.

Manufacturer and generic savings cards. Pfizer's branded Aldactone savings card is still available but offers limited value when generics cost less than many copays. Generic manufacturer discount programs are rare for a drug this inexpensive. The savings card arithmetic usually favors patients on brand-name medications priced above $50 per month.

Pharmacy discount programs. Walmart's $4 generic list includes spironolactone 25 mg tablets (30-day supply), making it one of the cheapest prescription medications available anywhere in Montana. The $4 price applies to the 25 mg strength; 50 mg and 100 mg tablets fall under slightly different pricing tiers, typically $9 to $15 for 30 tablets. Costco's member pharmacy pricing is similarly competitive, and Costco pharmacy services are available to non-members by federal law.

GoodRx, RxSaver, and similar aggregators. Free discount card platforms consistently show Montana prices for spironolactone 100 mg (30 tablets) between $7 and $14 at major chains. These platforms negotiate with pharmacy benefit managers to offer pre-negotiated rates that sometimes beat cash prices. No insurance is required. The discount is applied at the pharmacy counter with a coupon code.

Mark Cuban's Cost Plus Drugs. Cost Plus Drugs lists generic spironolactone at a transparent markup over wholesale acquisition cost. As of early 2026, their price for spironolactone 100 mg (30 tablets) is approximately $5 plus shipping. Montana residents can order through the mail-order pharmacy and receive medications shipped to their address 5.

340B programs. Federally Qualified Health Centers (FQHCs) in Montana, including Bullhook Community Health Center in Havre and Community Health Partners in Livingston, participate in the 340B drug pricing program. Eligible patients fill prescriptions at 340B contract pharmacies at significantly reduced prices, sometimes at no cost. The Health Resources and Services Administration oversees the 340B program, and eligibility is based on the patient being seen at a covered entity, not on income alone.

Telehealth Prescribing in Montana

Montana permits telehealth prescribing of spironolactone statewide. No in-person visit is required before a clinician can write a spironolactone prescription via telehealth, which is especially relevant for patients in Montana's rural and frontier counties where the nearest dermatologist may be 100 or more miles away.

The Montana Board of Medical Examiners requires that a telehealth prescriber establish a provider-patient relationship through a real-time audio-video encounter. Asynchronous (store-and-forward) encounters alone are not sufficient for initiating a new controlled substance prescription, but spironolactone is not a controlled substance, so asynchronous dermatology platforms can legally prescribe it in Montana.

HealthRX and similar telehealth platforms offer spironolactone consultations for Montana residents. The workflow is straightforward: complete a medical questionnaire, upload photos of affected skin areas, and connect with a licensed clinician. If spironolactone is appropriate, the prescription is sent to the patient's preferred Montana pharmacy or a partner mail-order pharmacy.

Baseline labs are recommended before starting spironolactone. The FDA label advises monitoring serum potassium and renal function, especially in patients taking concurrent ACE inhibitors, ARBs, or potassium supplements. A basic metabolic panel (BMP) covers both, and most Montana labs offer walk-in BMP draws for $15 to $30 without a separate office visit. Telehealth providers can order these labs electronically, and results route back to the prescriber digitally.

A retrospective cohort study of 6,930 healthy young women taking spironolactone for acne found that the rate of clinically significant hyperkalemia was 0.0% over a median 1.9-year follow-up, suggesting that routine potassium monitoring in otherwise healthy women under 45 may be unnecessary 6. Many dermatologists now skip baseline labs in young women without renal disease, diabetes, or concurrent potassium-altering medications, citing this evidence.

How Spironolactone Compares to Other Acne Treatments on Cost

Spironolactone's price profile in Montana is unusually favorable compared to other prescription acne therapies.

Isotretinoin (generic Accutane) costs $200 to $400 per month at Montana cash prices and requires monthly office visits, pregnancy testing, and iPLEDGE registration. Oral contraceptives used for acne range from $0 (fully covered under ACA preventive services) to $50 per month for brand-name formulations. Topical retinoids like tretinoin 0.025% gel cost $20 to $80 per month generic, and branded adapalene-benzoyl peroxide combinations can exceed $300 without insurance.

At $15 per month cash, spironolactone occupies a rare position: it is both clinically effective for hormonal acne and among the least expensive options. The Layton et al. review confirmed that spironolactone reduces acne lesion counts by 50% to 100% in most women at doses of 100 to 200 mg daily, with response typically visible by 12 weeks 2.

The American Academy of Dermatology's 2024 acne guideline update listed spironolactone as a recommended treatment for adult female acne, specifically noting its role as an alternative to isotretinoin in women with hormonal acne patterns. The guideline assigned a "conditional recommendation" based on moderate-quality evidence from multiple observational studies and small randomized trials.

When to Consider Alternatives

Spironolactone is not appropriate for everyone. It is contraindicated in pregnancy (FDA Category C, with feminization risk to male fetuses), in patients with hyperkalemia, Addison disease, or severe renal impairment, and in male patients seeking acne treatment due to anti-androgen effects including gynecomastia 1.

Women planning pregnancy within six months should discuss alternatives with their prescriber. Spironolactone should be discontinued at least one month before conception attempts. For these patients, topical retinoids (which must also be stopped before pregnancy but have shorter washout periods at lower systemic exposure) or benzoyl peroxide-based regimens may be more practical.

Male patients with acne should not use spironolactone. Alternatives for hormonal male acne include low-dose isotretinoin or topical combination therapies.

Monitoring requirements are minimal for most patients. The Plovanich et al. retrospective study (N=974) found no cases of hyperkalemia requiring intervention in healthy young women, supporting guidelines that recommend against routine lab monitoring in this population 6. For women over 45, those with renal disease, or those on potassium-sparing medications, a BMP at baseline and at 4 to 6 weeks after initiation remains standard practice per the Endocrine Society recommendations.